brain glucose metabolism was evaluated in four patients with acquired immunodeficiency syndrome ( aids ) dementia complex using [ 18f ] fluorodeoxyglucose ( fdg ) and positron emission tomography ( pet ) scans at the beginning of therapy with 3'-azido-2',3'-dideoxythymidine ( azt , zidovudine ) , and later in the course of therapy .
C0001175
acquired
C0043474
zidovudine